Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 4/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.32 |
| ▸ | MIF | P14174 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11951420 | 0.83 | TRPA1 (0.41) | TRPA1ESR1ESR2ACHE | |
| SCHEMBL23682289 | 0.82 | ALDH1A1 (0.44) | — | |
| SCHEMBL1845311 | 0.82 | ALDH1A1 (0.44) | — | |
| SCHEMBL28970410 | 0.80 | ALDH1A1 (0.43) | — | |
| SCHEMBL26635911 | 0.80 | TRPA1 (0.47) | TRPA1TAAR1AOC3 | |
| SCHEMBL26636039 | 0.80 | TRPA1 (0.47) | TRPA1TAAR1AOC3 | |
| SCHEMBL26635778 | 0.80 | TRPA1 (0.47) | TRPA1TAAR1AOC3 | |
| SCHEMBL5437162 | 0.78 | RIPK1 (0.36) | ESR1ESR2TAAR1 | |
| SCHEMBL590373 | 0.75 | TYR (0.46) | TRPA1IDO1 | |
| SCHEMBL9293367 | 0.75 | ESR1 (0.52) | ESR1ESR2IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 484 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3581600-B1 | RESIN LENS AND PREPARATION METHOD THEREFOR | EFIRM NEW MAT CO LTD (CN) | 2025-01-08 | — | — | EP | claimed |
| CN-118745246-A | High refractive material based on biomass magnolol and honokiol | 中国科学院上海有机化学研究所 | 2024-10-08 | — | — | CN | claimed |
| US-11548971-B2 | Method for producing a resin lens from a polyisocyanate and release agent at reduced pressure | YIFENG NEW MATERIALS CO., LTD. (CN) | 2023-01-10 | — | — | US | claimed |
| US-11402755-B2 | Chemically amplified positive-type photosensitive resin composition, method for manufacturing substrate with template, and method for manufacturing plated article | TOKYO OHKA KOGYO CO., LTD. (JP) | 2022-08-02 | — | — | US | claimed |
| CN-112500552-B | Polyisocyanate composition and polyurethane optical resin | 万华化学（宁波）有限公司 | 2022-07-12 | — | — | CN | claimed |
| US-20210221940-A1 | RESIN LENS AND METHOD FOR PRODUCING THE SAME | SHANDONG EFIRM BIOCHEMISTRY AND ENVIRONMENTAL PROTECTION CO., LTD. (CN) | 2021-07-22 | — | — | US | claimed |
| US-6391433-B1 | — | — | None | — | — | US | disclosed |
| US-12606692-B2 | Spectacle lens | HOYA LENS THAILAND LTD. (TH) | 2026-04-21 | — | — | US | disclosed |
| US-20260062548-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | KUREHA CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| US-20260062512-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | KUREHA CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| EP-3778170-B1 | METHOD FOR MANUFACTURING OPTICAL MEMBER | HOYA LENS THAILAND LTD (TH) | 2026-01-28 | — | — | EP | disclosed |
| US-12534563-B2 | Block copolymer, resin composition, stretch conductor, electronic device, and pressure-sensitive adhesive film | ARTIENCE CO., LTD. (JP) | 2026-01-27 | — | — | US | disclosed |
| EP-4667537-A1 | PRIMER COMPOSITION, LAMINATE, AND METHOD FOR PRODUCING LAMINATE | TOKYO OHKA KOGYO CO., LTD. (JP) | 2025-12-24 | — | — | EP | disclosed |
| US-5021503-A | Polythiourethanes from sulfur-containing aliphatic diisocyanates and polythiols or polyols; colorless | MITSUI TOATSU CHEMICALS, INC. (JP) | 1991-06-04 | — | — | US | disclosed |
| US-5013496-A | Polyurethane or polythiourethane | MITSUI TOATSU CHEMICALS, INC. (JP) | 1991-05-07 | — | — | US | disclosed |
| EP-0422836-A2 | Resin for urethane lenses, lenses comprising the resin, and a process for preparation of the resin and the lenses | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1991-04-17 | — | — | EP | disclosed |
| EP-0374258-A1 | HIGH REFRACTIVE INDEX LENS AND METHOD FOR ITS PRODUCTION | MITSUI CHEMICALS, INC. (JP) | 1990-06-27 | — | — | EP | disclosed |
| EP-0351073-A2 | Lens comprising a resin having a large refractive index and process for preparing the lens | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1990-01-17 | — | — | EP | disclosed |
| EP-0330363-A2 | Highly-refractive plastic lens and process for making the lens | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-08-30 | — | — | EP | disclosed |
| EP-0329387-A2 | Plastic lens, and method for its preparation | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-08-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062548-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | CROCC, WASF2, DCXR | TRPA1 1538/4885ESR1 2187/4885ESR2 2244/4885 |
| US-12534563-B2 | Block copolymer, resin composition, stretch conductor, electronic device, and pressure-sensitive adhesive film | EPB41, ITGB4, ITGB5 | TRPA1 1112/4885ESR1 193/4885ESR2 293/4885 |
| US-12606692-B2 | Spectacle lens | POT1, TCOF1, CRY1 | TRPA1 871/4885ESR1 2642/4885ESR2 1925/4885 |
| US-20260062512-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | EHMT1, EHMT2, ASH2L | TRPA1 369/4885ESR1 546/4885ESR2 686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.